1. Home
  2. BVS vs IVA Comparison

BVS vs IVA Comparison

Compare BVS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$13.63

Market Cap

982.2M

Sector

Health Care

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$3.63

Market Cap

895.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
IVA
Founded
2011
2011
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.2M
895.3M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
BVS
IVA
Price
$13.63
$3.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$14.00
$16.20
AVG Volume (30 Days)
460.2K
1.3M
Earning Date
05-06-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
N/A
EPS
0.52
N/A
Revenue
$568,087,000.00
N/A
Revenue This Year
$7.52
N/A
Revenue Next Year
$7.06
$751.20
P/E Ratio
$26.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.26
$3.35
52 Week High
$15.89
$7.98

Technical Indicators

Market Signals
Indicator
BVS
IVA
Relative Strength Index (RSI) 50.84 24.92
Support Level $13.44 $3.35
Resistance Level $14.71 $4.78
Average True Range (ATR) 0.51 0.25
MACD -0.08 -0.10
Stochastic Oscillator 51.85 3.09

Price Performance

Historical Comparison
BVS
IVA

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: